Concepedia

Nicholas Borys

NB

Statistics

Publications

7

Citations

670

H-Index

7

Active since

2001

Affiliations

Celsion (United States)(Current)

Washington University in St. Louis

University of Alabama at Birmingham

University of Oklahoma Health Sciences Center

Queen Mary Hospital

Nicholas Borys is an author at Celsion (United States) specializing in medicine, oncology, and chemotherapy.

ORCID

Publications per year

2001–2025

7

Publications

7

SPECT perfusion imaging in the diagnosis of Alzheimer’s disease

William Jagust, Ronald A. Thisted, Michael D. Devous et al. · Neurology · 2001 · 252 citations

, , +14

Phase III HEAT Study Adding Lyso-Thermosensitive Liposomal Doxorubicin to Radiofrequency Ablation in Patients with Unresectable Hepatocellular Carcinoma Lesions

Won Young Tak, Shi-Ming Lin, Yijun Wang et al. · Clinical Cancer Research · 2017 · 163 citations

, , +14

Two phase I dose-escalation/pharmacokinetics studies of low temperature liposomal doxorubicin (LTLD) and mild local hyperthermia in heavily pretreated patients with local regionally recurrent breast cancer

Timothy M. Zagar, Željko Vujašković, Silvia C. Formenti et al. · International Journal of Hyperthermia · 2014 · 107 citations · Full text

, , +13

Lyso-Thermosensitive Liposomal Doxorubicin: An Adjuvant to Increase The Cure Rate of Radiofrequency Ablation in Liver Cancer

Ronnie T. P. Poon, Nicholas Borys · Future Oncology · 2011 · 100 citations

, , +13

GEN-1 in Combination with Neoadjuvant Chemotherapy for Patients with Advanced Epithelial Ovarian Cancer: A Phase I Dose-escalation Study

Premal H. Thaker, William H. Bradley, Charles A. Leath et al. · Clinical Cancer Research · 2021 · 25 citations · Full text

, , +17

1–5 of 7